anmelden
Analysen von James Quigley
| 06.08.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 05.08.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 06.07.26 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 06.07.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 30.06.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 30.06.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 25.06.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 23.06.26 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 04.06.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 06.05.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 29.04.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 27.04.26 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 24.04.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 23.04.26 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 23.04.26 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 20.04.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 16.04.26 | Merck Buy | Goldman Sachs Group Inc. | |
| 31.03.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 31.03.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 30.03.26 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 30.03.26 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 20.03.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 17.03.26 | Sartorius Stedim Biotech Neutral | Goldman Sachs Group Inc. | |
| 17.03.26 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 16.03.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 09.03.26 | Merck Buy | Goldman Sachs Group Inc. | |
| 09.03.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 06.03.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 05.03.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 05.03.26 | Merck Buy | Goldman Sachs Group Inc. | |
| 04.03.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 02.03.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 24.02.26 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 23.02.26 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 18.02.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 10.02.26 | Merck Buy | Goldman Sachs Group Inc. | |
| 09.02.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 06.02.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 04.02.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 04.02.26 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 03.02.26 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 02.02.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 30.01.26 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 30.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 27.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 22.01.26 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 21.01.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 19.01.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 16.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 15.01.26 | Sanofi Neutral | Goldman Sachs Group Inc. | |
